论文部分内容阅读
目的探讨在盐酸氨溴索静脉输注治疗新生儿肺炎的基础上,应用普米克令舒联合异丙托溴铵雾化吸入加强呼吸道管理辅助治疗的疗效。方法将临床确诊为新生儿感染性肺炎的94例患儿随机分为两组,对照组给予盐酸氨溴索单纯静脉输注给药,观察组在给予盐酸氨溴索静脉输注的基础上给予普米克令舒联合异丙托溴铵雾化吸入辅助治疗,比较两组患者的治疗效果及住院时间。结果观察组患儿治疗后总有效率高于对照组,住院时间短于对照组。两组内比较有显著性差异。结论在常规应用盐酸氨溴索静脉输注治疗新生儿感染性肺炎的基础上,普米克令舒联合异丙托溴铵雾化吸入加强气道管理可缩短病程,总有效率高,可作为辅助治疗新生儿感染性肺炎的主要药物。
Objective To investigate the efficacy of inhalation of ambroxol combined with ipratropium bromide in the adjuvant therapy of respiratory tract management on the basis of intravenous infusion of ambroxol hydrochloride in the treatment of neonatal pneumonia. Methods Ninety-four children with clinically diagnosed as neonatal pneumonia were randomly divided into two groups. The control group was treated with ambroxol hydrochloride alone. The observation group was given intravenous ambroxol hydrochloride Pulmicort respules with ipratropium bromide inhalation adjuvant therapy, the treatment effect and hospital stay in two groups were compared. Results The total effective rate of observation group after treatment was higher than that of control group, and the hospitalization time was shorter than that of control group. There were significant differences between the two groups. Conclusion In the routine application of intravenous infusion of ambroxol hydrochloride in the treatment of neonatal pneumonia, on the basis of pulmicort and ipratropium bromide inhalation to enhance airway management can shorten the course of the disease, the total effective rate can be used as a supplement Treatment of neonatal infectious pneumonia, the main drug.